Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients
Open Access
- 7 August 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11, 899
Abstract
Malignant pleural mesothelioma (MPM), predominantly caused by asbestos exposure, is a highly aggressive cancer with poor prognosis. The staging systems currently used in clinics is inadequate in evaluating the prognosis of MPM. In this study, a five-gene signature was developed and enrolled into a prognostic risk score model by LASSO Cox regression analysis based on two expression profiling datasets (GSE2549 and GSE51024) from Gene Expression Omnibus (GEO). The five-gene signature was further validated using the Cancer Genome Atlas (TCGA) MPM dataset. Univariate and multivariate Cox analyses proved that the five-gene signature was an independent prognostic factor for MPM. The signature remained statistically significant upon stratification by Brigham stage, AJCC stage, gender, tumor size, and lymph node status. Time-dependent receiver operating characteristic (ROC) curve indicated good performance of our model in predicting 1- and 2-years overall survival in MPM patients. The C-index was 0.784 for GSE2549 and 0.753 for the TCGA dataset showing moderate predictive accuracy of our model. Furthermore, Gene Set Enrichment Analysis suggested that the five-gene signature was related to pathways resulting in MPM tumor progression. Together, we have established a five-gene signature significantly associated with prognosis in MPM patients. Hence, the five-genes signature may serve as a potentially useful prognostic tool for MPM patients.Keywords
This publication has 73 references indexed in Scilit:
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-AnalysisJournal of Clinical Oncology, 2012
- Epithelial–mesenchymal transition in malignant mesotheliomaLaboratory Investigation, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural MesotheliomaThe Journal of Molecular Diagnostics, 2010
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in MammalsDevelopmental Cell, 2010
- L1Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010
- Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour TargetPLOS ONE, 2009
- Rho GTPases in cancer cell biologyFEBS Letters, 2008
- Adaptive Lasso for Cox's proportional hazards modelBiometrika, 2007
- Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional ProfilingThe American Journal of Pathology, 2005